FGF21: An Emerging Therapeutic Target for Non-Alcoholic Steatohepatitis and Related Metabolic Diseases.

Front Endocrinol (Lausanne) · 2020 · PMC7767990 · PMID 33381084

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

However, modest decreases in glucose, insulin, and HOMA-IR (homeostatic model assessment for insulin resistance) did not reach statistical significance ( 183 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.